Cargando…
A randomized, active-controlled, parallel, open-label, multicenter, phase 4 study to compare the efficacy and safety of pregabalin sustained release tablet and pregabalin immediate release capsule in type II diabetic patients with peripheral neuropathic pain
Diabetic peripheral polyneuropathy is the most common chronic complication of type 2 diabetes. Neuropathic pain is challenging to manage, and various drugs are required to control it, decreasing treatment adherence. Pregabalin, a ligand that binds to alpha-2-delta subunits of the presynaptic calcium...
Autores principales: | Kang, Seon Mee, Hong, Jun Hwa, Ku, Bon Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145715/ https://www.ncbi.nlm.nih.gov/pubmed/37115054 http://dx.doi.org/10.1097/MD.0000000000033701 |
Ejemplares similares
-
A clinical study to compare the efficacy and safety of pregabalin sustained release formulation with pregabalin immediate release formulation in patients of diabetic peripheral neuropathic pain
por: Srivastava, A., et al.
Publicado: (2012) -
Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 Trial
por: Han, Kyung Ah, et al.
Publicado: (2022) -
Sustained-release pregabalin with methylcobalamin in neuropathic pain: an Indian real-life experience
por: Dongre, Yasmin U, et al.
Publicado: (2013) -
Preclinical Evaluation of Polymeric Nanocomposite Containing Pregabalin for Sustained Release as Potential Therapy for Neuropathic Pain
por: Rodrigues, Rafaela Figueiredo, et al.
Publicado: (2021) -
Preparation and characterization of ethylcellulose microspheres for sustained-release of pregabalin
por: Yasin, Haya, et al.
Publicado: (2020)